Clinical Trial Update: Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating immunosuppression in liver transplant patients with hepatocellular carcinoma has completed. The update notes the completion status of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Regensburg | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED